Transitioning a rare disease HUB or NCP program to a rare-focused partner can yield major service quality improvements without program disruption.
DSCSA Beyond the November Deadline: Operationalize Compliance in the Warehouse
December 12th 2024Compliance with the Drug Supply Chain Security Act (DSCSA) is crucial to ensure a secure and efficient pharmaceutical supply chain. Industry experts share strategies for implementing serialized data tracking, overcoming compliance challenges, and fostering collaboration across the supply chain to maintain operational efficiency and patient safety.
Machine Health in Pharmaceutical Production (Nov 2024)
December 2nd 2024Predictive maintenance in pharmaceutical production can help reduce downtime and increase efficiency. Grundfos Machine Health (GMH) uses artificial intelligence (AI)-driven wireless sensors to monitor motor health in real-time, identifying potential issues. This approach not only reduces maintenance costs but also ensures compliance with industry standards.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.